3 FDA Members Quit After FDA Approves Alzheimer's Drug- LACK OF SAFETY

First published at 18:27 UTC on June 24th, 2021.
subscribers

An FDA adviser who resigned in protest of an Alzheimer's drug approval says he's concerned about the agency's standards. Dr. Tara Narula explains why there are concerns about the drug's safety. The therapy — costs $56,000 per yea…

MORE
CategoryNone
SensitivityNormal - Content that is suitable for ages 16 and over
DISCUSS THIS VIDEO